OKYO Pharma (NASDAQ:OKYO) Receives “Buy” Rating from HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of OKYO Pharma (NASDAQ:OKYO) in a research note released on Tuesday morning,Benzinga reports. They currently have a $7.00 target price on the stock.

OKYO Pharma Stock Down 0.9 %

OKYO stock opened at $1.09 on Tuesday. OKYO Pharma has a one year low of $0.81 and a one year high of $1.90. The company has a fifty day moving average price of $1.09 and a two-hundred day moving average price of $1.07.

About OKYO Pharma

OKYO Pharma Limited, a clinical-stage biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead preclinical product candidate is OK-101, which is in Phase II clinical trials for the treatment of dry eye disease.